April 2024 – News Letter

As we step into the spring of 2024, we are delighted to present the latest edition of Patient Guard’s Newsletter, dedicated to providing you with insightful updates and invaluable resources in medical device and In Vitro Diagnostics (IVD) regulatory affairs and quality assurance consultancy. We have been busy updating our website to change it from a generic consultancy website to an informative resource for medical device and IVD information.
Hello April, spring related motivational quote, isolated on white background, vector illustration. Handwritten letters, Japanese sakura branch, little cute flowers falling. Used by Patient Guard Medical Device and IVD Regulatory and Quality Assurance consultancy agency for their April news letter.

Message from our Founder

Dear Valued Clients and Partners,

As we step into the spring of 2024, we are delighted to present the latest edition of Patient Guard’s Newsletter, dedicated to providing you with insightful updates and invaluable resources in medical device and In Vitro Diagnostics (IVD) regulatory affairs and quality assurance consultancy.

We have been busy updating our website to change it from a generic consultancy website to an informative resource for medical device and IVD information. We also attended the Medical Technology Exhibition in Coventry in March, where we met lots of people with new and interesting medical device ideas they are developing.

We will be attending the Medtech Exhibition at Birmingham NEC arena in June 2024.

We wish you a lovely April and look forward to engaging with you soon.

Best wishes

David Small – Founder of Patient Guard

Image of our founder David Small he is the CEO of Patient Guard Group

Regulatory News

EU

UK

FDA

The words "breaking news" - with breaking with a red background and news with a blue background. Used by patient guard for their news letter.

Important Deadline - 26th May 2024

If you currently sell CE marked legacy devices under MDD in the EU or the UK which requires a Notified Body under MDR, then you must have a contract in place with a Notified Body for MDR to take advantage of the certificate extensions under article 120 to allow you to continue to place your devices on the market under MDD until 2027/2028.

CE marked devices under MDD in the UK which require a Notified Body must upload their extension certificates on the MHRA portal to remain compliant.

This does not apply to UKCA marked devices or devices that do not require a Notified Body under CE marking.

New medical devices are required to follow MDR for CE marking.

Updated MDCG Guidelines

  • MDCG 2024-3 – Guidance on content of the Clinical Investigation Plan for clinical investigations of medical devices

Updated MHRA Guidelines

  • Notify the MHRA about a clinical investigation for a medical device

illustration of a form and a magnifying glass (spy glass) - used by patient guard for their blog relating to medical device post market surveillance (PMS).

New/updated Standards issued

  • ISO 17665:2024 – Sterilization of health care products. Moist heat. Requirements for the development, validation and routine control of a sterilization process for medical devices

  • IEC 80601-2-58:2024 – Medical electrical equipment. – Part 2-58: Particular requirements for the basic safety and essential performance of lens removal devices and vitrectomy devices for ophthalmic surgery

  • ISO 18562-4:2024 – Biocompatibility evaluation of breathing gas pathways in healthcare applications – Tests for leachables in condensate

  • BS EN ISO 20916:2024 – In vitro diagnostic medical devices. Clinical performance studies using specimens from human subjects. Good study practice

  • BS EN IEC 80601-2-26:2020+A1:2024 – Medical electrical equipment – Particular requirements for the basic safety and essential performance of electroencephalographs

  • BS ISO 5832-11:2024 – TC – Implants for surgery. Metallic materials – Wrought titanium 6-aluminium 7-niobium alloy

Most Popular

Post Market Surveillance – Medical Devices

Post-market surveillance (PMS) is a pivotal aspect that governs the continued monitoring and assessment of medical devices after they have entered the market. Across the EU, UK, and USA, distinct regulatory frameworks shape PMS protocols, fostering safety, and innovation simultaneously.

Read More »

December 2024 News Letter

Welcome to our December 2024 news letter, here we share the latest medical device regulatory news from the EU, UK and the USA as well as updated or new medical device standards that have been issued.

Read More »

Medical Device Clinical Evaluation

Medical device clinical evaluation is an essential part of regulatory compliance. Clinical Evaluation is a review of all the data that has been generated by the medical device manufacturer; pre-clinical, clinical and post market. The review of this data is performed to assess that the benefits of using the medical device outweigh the risks associated with using the medical device within the devices clinical intended purpose. 

Read More »
patient guard
Patient Guard

Sign up to our newsletter

Be the first to hear industry news and how Patient Guard can help you.

Get the latest updates on medical device regulation

Sign up to our newsletter and we’ll deliver news and insights straight to your inbox.

Patient Guard Regulatory Affairs and Quality Assurance

Do you need support with Medical Device or IVD compliance?

We can help you!